Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    CALC - Chinese Alliance Against Lung Cancer Session

    • Type: Other Sessions
    • Track: Other Topics
    • Presentations: 15
    • Moderators:C. Bai
    • Coordinates: 10/27/2013, 07:30 - 12:00, Parkside Auditorium, Level 1
    • +

      CALC.03 - Pathogenesis and Pathology of Never Smoking Lung Cancer

      08:30 - 08:50  |  Author(s): A.F. Gazdar

      • Abstract

      Loading...

    • +

      CALC.08 - Targeted Therapies for Adenocarcinoma, Now and Future

      10:25 - 10:45  |  Author(s): C. Zhou

      • Abstract

      Loading...

  • +

    P1.06 - Poster Session 1 - Prognostic and Predictive Biomarkers

    • Type: Poster Session
    • Track: Biology
    • Presentations: 59
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.06-040 - The Bim Deletion Polymorphism profile and its relationship with TKIs Resistance in Chinese NSCLC Population

      09:30 - 09:30  |  Author(s): Y. Zhang

      • Abstract

      Loading...

  • +

    P1.10 - Poster Session 1 - Chemotherapy

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 57
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.10-008 - Clinical Significance of Hyperpigmentation due to Pemetrexed Treatment in Advanced Non-Squamous Non-small cell lung cancer in China

      09:30 - 09:30  |  Author(s): Q. Hu

      • Abstract

      Loading...

  • +

    P1.11 - Poster Session 1 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 45
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.11-021 - First-line erlotinib versus cisplatin/gemcitabine (GP) in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC): interim analyses from the phase 3, open-label, ENSURE study

      09:30 - 09:30  |  Author(s): Y. Wu

      • Abstract

      Loading...

  • +

    P1.18 - Poster Session 1 - Pathology

    • Type: Poster Session
    • Track: Pathology
    • Presentations: 22
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.18-001 - The prevalence and clinicopathologic feature of ALK, ROS1 and RET fusions in East Asian patients with lung adenocarcinoma

      09:30 - 09:30  |  Author(s): W. Cai

      • Abstract

      Loading...

  • +

    O01 - Prognostic and Predictive Biomarkers I

    • Type: Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 8
    • Moderators:T. Mitsudomi
    • Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Auditorium, Level 1
    • +

      O01.05 - EGFR wild-type NSCLC patients with high miR-200c expression can benefit from EGFR-TKI

      11:15 - 11:25  |  Author(s): J. Li

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    O06 - Cancer Control and Epidemiology I

    • Type: Oral Abstract Session
    • Track: Prevention & Epidemiology
    • Presentations: 8
    • Moderators:C. Dresler
    • Coordinates: 10/28/2013, 10:30 - 12:00, Bayside 104, Level 1
  • +

    MO06 - NSCLC - Chemotherapy I

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 14
    • Moderators:R. Perez-Soler
    • Coordinates: 10/28/2013, 16:15 - 17:45, Parkside Ballroom A, Level 1
    • +

      MO06.13 - BEYOND: a randomized, double-blind, placebo-controlled, multicentre, phase III study of first-line carboplatin/paclitaxel (CP) plus bevacizumab (Bv) or placebo (Pl) in Chinese patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC)

      17:25 - 17:30  |  Author(s): C. Zhou

      • Abstract

      Loading...

  • +

    MO07 - NSCLC - Targeted Therapies II

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 14
    • Moderators:T. John
    • Coordinates: 10/28/2013, 16:15 - 17:45, Bayside Auditorium B, Level 1
    • +

      MO07.02 - Clinical experience with crizotinib in patients with advanced ALK-rearranged non-small cell lung cancer and brain metastases in PROFILE 1005 and PROFILE 1007

      16:20 - 16:25  |  Author(s): D.B. Costa

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.02 - Poster Session 2 - Novel Cancer Genes and Pathways

    • Type: Poster Session
    • Track: Biology
    • Presentations: 21
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.02-011 - Impact of Family History of Cancer on the Incidence of Mutation in Epidermal Growth Factor Receptor Gene in Non-small Cell Lung Cancer Patients

      12:20 - 12:37  |  Author(s): Y. He

      • Abstract

      Loading...